Corcept Therapeutics

About The Fund

Corcept Therapeutics is a specialized investment fund that focuses on backing innovative ventures within the software industry, specifically in domains such as Web Marketplaces, SaaS (Software as a Service), and other emerging digital platforms. Their investment thesis leans towards early-stage companies, where they come in as a seed investor, poised to support startups that demonstrate the potential for significant impact and growth in their respective markets. They actively engage with founders who are at the precipice of scaling their ventures, providing not only capital but also strategic guidance to navigate the complex landscape of software development and market entry. With a hands-on approach, Corcept Therapeutics concentrates on identifying disruptive technologies and business models that can transform existing market dynamics. Fostering a portfolio of companies that lead with innovation, user-centric designs, and scalable solutions, they aim to be a catalyst for progression in a rapidly evolving digital economy. This focus on the foundational stage equips startups with the essential resources required to refine their product offerings, accelerate growth, and establish a robust foothold within their niche sectors. As a seed investor, their endorsement is often viewed as a testament to a startup's potential, bridging the gap between nascent concepts and market-ready solutions.